Methylmalonic acid (MMA) accumulates in tissues in methylmalonic acidemia, a heterogeneous group of inherited childhood diseases characterized by neurological dysfunction, oxidative stress and neuroinflammation; it is associated with degeneration of striatal neurons and cerebral cortical atrophy. It is presently unknown, however, whether transient exposure to MMA in the neonatal period is sufficient to trigger inflammatory and apoptotic processes that lead to brain structural damage. Here, newborn mice were given a single intracerebroventricular dose of MMA at 12 hours after birth. Maze testing of 21-and 40-day-old mice showed that MMA-injected animals exhibited deficit in the working memory test but not in the reference test. MMA-injected mice showed increased levels of the reactive oxygen species marker 2 0 ,7 0 -dichlorofluorescein diacetate, tumor necrosis factor, interleukin-1b, caspases 1, 3, and 8, and increased acetylcholinesterase activity in the cortex, hippocampus and striatum. This was associated with increased astrocyte and microglial immunoreactivity in all brain regions. These findings suggest that transient exposure to MMA may alter the redox state and cause neuroinflammatory/apoptotic processes and glial activation during critical periods of brain development. Similar processes may underlie brain dysfunction and cognitive impairment in patients with methylmalonic acidemia.
INTRODUCTION
Glia play key roles in brain development. They are essential for the generation of synapses (1), blood-brain barrier formation (2) , and axon development (3, 4) . Developing glial cells are vulnerable to ischemia (5) , oxidative stress (6) , and inflammation (7, 8) . Primary and secondary glial damage have been implicated in several developmental and perinatal CNS disorders (6, 9) . Thus, vulnerability of glia in early stages of development may critically alter subsequent cerebral development and cause neurological structural abnormalities and dysfunction.
Methylmalonic acidemia is an autosomal recessive inherited neurometabolic disease caused by tissue accumulation of methylmalonic acid (MMA) and its metabolites such as propionate, methylcitrate, and b-OH propionate; it is due to deficiency of L-methylmalonyl-CoA mutase ([MCM]; EC 5.5.99.2) enzymatic activity (10) (11) (12) . The clinical manifestations of methylmalonic acidemia are mainly neurological and include mental retardation, cerebral atrophy, seizures, and cognitive disability. The pathological abnormalities that underlie these conditions often have their onset in the first week of life after encephalopathic crises (13, 14) . Marked loss of basal ganglia neurons may be a characteristic neuropathological feature of these disorders.
It is possible that during episodes of elevated MMA, which may be triggered by infections and other conditions that are associated with metabolic stress, there are increases of MMA levels in tissues and bodily fluids (15) . Previous studies have considered MMA to be the major neurotoxin in methylmalonic academia but mechanisms underlying this toxicity are not well established. Increasing evidence suggests that excitotoxicity (16) (17) (18) (19) , free radical generation (20, 21) , inflammation (22, 23) , and apoptosis play central roles in the neuropathogenesis of this disease. In line with this view, studies have shown that neurological manifestations in methylmalonic acidemia may be associated with neural apoptosis (24, 25) .
Neuroinflammatory responses are characterized activation of microglia and increased cytokine levels (26) , which can lead to cerebral dysfunction (27) , and learning or memory deficits (28) . For example, central bacterial lipopolysaccharide injection activates microglia, potently blocks neuronal differentiation and disrupts the integration of neurons into the existing hippocampal circuit (29) (30) (31) . Our group showed that a lipopolysaccharide-induced increase in cytokine levels leads to cognitive deficits in an experimental memory impairment model (32) .
Although neuroinflammation has been shown to play a central role in human neurological diseases such as epilepsy (33) , autism (34) , multiple sclerosis (35) , and glutaric academia (32) , there are few studies on the relationship between methylmalonic acidemia and the above-mentioned conditions. Therefore, the objective of this study was to determine whether acute exposure of the brain to MMA during the neonatal period in mice is sufficient to trigger inflammatory/apoptotic processes and lead to brain injury and dysfunction, eg by altering behavioral parameters.
MATERIALS AND METHODS

Animals and Reagents
This study utilized male newborn Swiss mice. Pregnant Swiss mice were housed in individual cages and left undisturbed during gestation. Twenty-four hours after delivery, litters were culled to 6 male pups. The pups were fed by the mother from birth until they were 21-days old, at which point they were weaned. All animals had free access to water and standard commercial chow and were maintained on a 12/12-hour light/dark cycle in an air-conditioned constant temperature (24 6 1 C, 55% relative humidity) colony room. Male pups were used to avoid confusing factors, (eg later effects of estrogen in females). Animals were divided to have the same numbers of mice for each treatment in each cage.
MMA Administration and Drug Treatment
MMA (2.5 lmol/g, pH 7.4; [i.e. a concentration found in the brains of affected patients]) or the vehicle sodium chloride ([NaCl] 0.9%) was intraventricularly administered directly into the cisterna magna at 12 hours after birth (P0) (36, 37) . Because patients with methylmalonic acidemia present with neurological signs early in life, we used this period for MMA injection, based on the study of OliveraBravo et al (38) . Although the critical periods of prenatal and early postnatal development may be the ideal time in the lifespan to make the most accurate cross-species comparisons and conversions become more variable in adult animals (39) , behavioral tests were conducted when the mice were 21-days old (because mouse pups open their eyes and are weaned at this age) and 40-days old (to determine whether behavioral, biochemical, and immunohistochemical parameters persisted to later life).
The external reference point used to locate the cisterna magna was the intersection between bones, i.e. the meeting point of the bone sutures bregma and lambda and the interaural line. The animals were anesthetized using a mixture of local anesthetics cream (2.5% lidocaine/2.5% prilocaine) (40, 41) , and were then injected directly into the cisterna magna with a 30-gauge needle. The following parameters were used for the injections: anterior posterior ¼ À2.7 mm (later the interaural line), vertical (V) ¼ À1 mm (below the dura mater), lateral (L) ¼ 0, angle (H) ¼ 90 (42) . All drugs were injected within a period of 2 minutes using a Hamilton syringe. Animal weights were determined on a weekly basis by one experimenter who was not aware of the subject conditions. The experimental protocol is described in Figure 1 . Behavioral development was assessed in all mice.
Open-Field Task
Locomotor activity was measured for 5 minutes in the open field. The apparatus consisted of a wooden box measuring 60 Â 40 Â 50 cm with a glass front wall. The floor was divided into 12 equal squares by black lines. Animals were gently placed facing the rear left corner of the arena, and numbers of squares crossed by the 4 paws were recorded for 5 minutes to evaluate locomotor and exploratory activity (43) . Two observers were needed for this test. The testing room was dimly illuminated with indirect white lighting.
Radial Arm Maze Test
The radial arm maze (RAM) consisted of 8 wooden arms, which were secured to a wooden base and elevated 100 cm from the floor. The RAM was 35 cm in length, with 2.6-cm-high outer arm walls and 15 cm in height by 5.8 cm in width inner arm walls. The central well of the maze was 16.7 cm in diameter, and the maze was situated in the middle with moderate luminosity (44, 45) . Food wells were located at the end of each arm. Cornflake chips were used as reinforcement and were placed in circular plastic Petri dishes that were attached to the ends of the maze arms. Four open Petri dishes without lids were used to house the obtainable chips in the reinforced arms. In the nonreinforced arms, 4 other Petri dishes, with lids that had several small holes drilled through them, contained cornflake chips. Therefore, the mice could not obtain these chips, but the odor of the chips was allowed to permeate from the dishes, preventing the rats from solving the task using the smell of the cornflakes. In a separate group of mice, the ability to solve the RAM test was assessed.
Starting in the first week of the procedure, training sessions for this test were carried out for 12 days (D1-D12; the memory test was implemented on D9). During this acquisition period, animals were trained to find the cornflake chips in 4 randomly selected arms. Animals were subjected to 3 trials lasting 5 minutes/day or until the mouse collected all the packages (46, 47) . Three types of errors were scored: reference memory errors (RMEs), defined as the number of first entries into an unabated arm; "correct" working memory errors (CWME), defined as the number of reentries into a baited arm; and "incorrect" working memory errors (ICWME), defined as the number of reentries into an unabated arm (48, 49) .
Elevated plus Maze Task
Based on the design of File and Gonzalez (50, 51) , the maze consisted of 2 opposite closed arms (30 Â 5 cm) enclosed by walls (15 cm in height) and 2 opposite open arms (also 30 Â 5 cm, without edges), forming a plus shape.
The whole apparatus had a central arena (5 Â 5 cm) and was elevated to 80 cm above the floor by a tripod. Each mouse was placed in the arena of the maze facing an open arm and was observed for 5 minutes. The following behaviors were recorded: the total number of entries, the percentage of time spent on either arm, and the percentage of time spent in the middle arena. The apparatus was cleaned thoroughly with a 30% ethanol solution between the observation sessions.
Tissue Processing for Neurochemical Analyses
Immediately after the behavioral evaluation, the animals were killed by decapitation and had their brains exposed by removing the parietal bone. The cerebral cortex, hippocampus and striatum were dissected on an inverted ice-cold Petri dish and homogenized in cold 10 mM Tris-HCl buffer (pH 7.4). The homogenate was then divided into aliquots for subsequent neurochemical analyses.
Interleukin-1b and Tumor Necrosis Factor Immunoassay
The cerebral cortex, hippocampus, and striatum were weighed and then homogenized in a solution containing bovine serum albumin ([BSA] 10 mg/mL), EGTA (2 mM), EDTA (2 mM), and PMSF (0.2 mM) in phosphate-buffered FIGURE 1. Experimental design. Representation of the experimental design of intra-cisterna magna MMA administration (2.5 mmol/g) on the day of birth (P0). The behavioral and biochemical analysis was conducted on 21-and 40-day-old mice. Histologic analysis was conducted after the RAM task (33-and 52-day-old mice).
saline ([PBS] pH 7.4) using a Potter homogenizer. The homogenate was centrifuged (3000 Â g for 10 minutes), and cytokine levels in the supernatant were determined. Cytokine levels were measured using a commercially available ELISA Kit from R&D Systems (Minneapolis, MN) using an antibody against mouse IL-1b or tumor necrosis factor (TNF), according to the manufacturer's protocol. The results were expressed in pg/mg protein for the cerebral cortex, hippocampus and striatum homogenate assays. Absorbance was read at 405 nm. The detection limit was 4 ng/mL.
DCFH Oxidation
The production of reactive oxygen species and nitrogen was measured using 2 0 ,7 0 -dichlorofluorescein-diacetate (DCF-DA). The oxidant H 2 O 2 , derived from Fe 2þ , is mainly responsible for the nonenzymatic oxidation of DCF. DCF was prepared in 20 mmol/L sodium phosphate buffer, pH 7.4, containing 140 mmol/L KCI solution and incubated with 100 lL of supernatant for 30 minutes at 37 C. DCF-DA is enzymatically hydrolyzed by intracellular esterases to form nonfluorescent DCF, which is rapidly oxidized and forms 2 0 ,7 0 -dichlorofluorescein (DCF), which is highly fluorescent in the presence of reactive oxygen species. The fluorescence intensity of DCF is proportional to the amount of reactive oxygen species formed. The fluorescence was then measured using excitation and emission wavelengths of 480 and 535 nm, respectively. The calibration curve was constructed using standard DCF concentrations (0.25-10 mmol), and the levels of reactive oxygen species were calculated as pmol DCF formed by mg/protein (52).
Acetylcholinesterase Activity
Acetylcholinesterase (AChE) activity was measured according to the method described by Ellman et al (53) . The hydrolysis of acetylcholine (ACh) was evaluated at a concentration of 0.8 mM in 1 mL of solution containing 100 mM phosphate buffer (pH 7.5) and 1.0 mM DTNB. Fifty lL of sample was added to the solution and pre-incubated for 3 minutes. Hydrolysis was monitored by the formation of the thiolate dianion of DTNB at 412 nm for 3.2 minutes at intervals of 30 seconds at a temperature of 25 C. All samples were analyzed in duplicate.
Isolation and Cell Culture
For isolation and cell culture, the cerebral cortex, hippocampus and striatum were collected from 12 mouse pups (21-and 40-days old) that had previously been treated with saline or MMA. The animals were killed and the structures were removed using sterile materials. After removal, the specimens were placed in Petri dishes containing 2 mL of glycosylated Hanks solution and were sectioned and slightly macerated.
Shortly thereafter, the materials were filtered, and the content was prepared in 15-mL falcon tubes. Then, 4 mL of Dulbecco's modified Eagle's medium supplemented with 10% Fetal bovine serum, 1% penicillin/streptomycin, and 1% antifungal amphotericin B was added. The content was homogenized and centrifuged for 10 minutes at 2000 rpm, the supernatant was removed and the cell pellet was then resuspended in complete culture medium.
Cells isolated from each frame of interest were prepared in sterile 96-well ELISA plates, with 200 lL per well, and were kept at optimal cell culture conditions in a CO 2 incubator at 37 C and 5% CO 2 saturation for 24 hours to stabilize the cells. After the incubation period, the cultures were tested for apoptosis-related proteins, including the initiator and effector caspases 1, 3, and 8, using the Human Caspase Quantikine Immunoassay Kit (Quantikine Human Caspase Immunoassay (54) .
Histology
After the RAM test, the mice were killed for histologic analysis. Under deep anesthesia (ketamine hydrochloride, 200 mg/kg, i.p.) they were transcardially perfused with 100 mL of heparinized saline (1000 UI/mL), followed by 100 mL of formaldehyde (4%) in PBS (0.1 M). The brains were then carefully removed from the skull. Briefly, serial sections from bregma levels þ2 to À4 (55), spaced 500 lm apart, were stained with hematoxylin and eosin (H&E), and digitally photographed using a stereomicroscope (Olympus BX51) with a digital camera (Olympus DP25). Images of the striatum, cerebral cortex, and hippocampus were traced on each image by a pathologist using a microscope at 4Â magnification.
Immunohistochemistry
Perfusion and fixation of the brain was performed by trans-cardiac perfusion with 4% paraformaldehyde (in 0.9% sodium chloride and 4% sucrose from Sigma-Aldrich, Portugal). Frozen brains were sectioned (20 lm coronal sections) using a cryostat Leica CM1850 (Leica Microsystems, Porto Alegre, Brazil), and the sections were mounted on slides coated with 2% gelatin plus 0.08% chromalin (chromium and potassium sulfate, from Sigma-Aldrich, Brazil), allowed to dry at room temperature and stored at À20 C until use.
Immunohistochemical detection of the microglia antigen CD11b and the astrocyte protein glial fibrillary acidic protein (GFAP) was carried out to evaluate microgliosis and astrogliosis, respectively, in the striatum, cerebral cortex and hippocampus. The sections were first rinsed with PBS for 5 minutes and then washed 3 times with Trizma base buffer ([TBS] 0.05 M, containing 150 mM NaCl, pH 7.2) for 5 minutes at room temperature. Sections were then permeabilized and blocked with TBS containing 0.2% Triton X-100 and 10% goat serum for 45 minutes and then incubated in the presence of the mouse antiCD11b (1:50, Abcam, Brazil) or anti-GFAP (1:50, Santa Cruz Biotechnology, Brazil) for 72 hours at 4 C. Then, the sections were rinsed in TBS 3 times for 10 minutes each and subsequently incubated with goat antimouse secondary antibody conjugated with the fluorophores Alexa Fluor 488 and Alexa Fluor 594 (for both, 1:500, Santa Cruz Biotechnology, Brazil) for 2 hours at room temperature. After rinsing in TBS twice for 10 minutes and in distilled water once for 10 minutes, the sections were dehydrated and passed through xylenes before being mounted on slides using DPX mounting medium (Sigma Aldrich). All sections were examined under a transmission and fluorescence Olympus/IX70 microscope, and the section images were analyzed with Image J Software (National Institutes of Health, Bethesda, MD).
Cresyl Violet Staining
Neuronal morphology in hippocampal, cerebral cortex and striatum sections was evaluated by Cresyl violet stain, as previously described in (56) . Briefly, sections were incubated for 10 minutes with Cresyl violet-positive (Sigma-Aldrich, Sao Paulo, Brazil) solution (0.5% in acetate buffer). Sections were then washed twice with acetate buffer, twice in 100% ethanol, cleared with xylene and mounted with DPX mounting medium (Sigma Aldrich).
Western Blot
The technique follows that in reference (57) , with some modifications. Proteins from brain homogenates were subjected to 10% SDS-polyacrylamide gel electrophoresis. Membranes stained with 0.1% Ponceau solution served as the transfer control (58); they were photographed, washed with Trisbuffered saline containing 0.04% (v/v) Tween 20 (TBS-T) until removal of the Ponceau. Each piece of membrane was blocked with 5% (w/v) BSA in TBS-T for 1 hour. They were then incubated overnight at 4 C with a 1:3000 dilution of anti-GFAP antibody (Santa Cruz Biotechnology, sc-9065) in TBS containing 2.5% BSA in TBS-T. Membranes were washed 3 times in TBS-T and incubated for 1 hour with biotinylated antimouse secondary antibody conjugated with streptavidin peroxide (1:10 000, Thermo Fisher Scientific, 31432) in TBS containing 2.5% BSA. Finally, membranes were developed in fotodocumentador (Carestream Molecular imagingGel Logic 6000 PRO) for capturing luminescence produced by the Western blotting substrate ECL (Pierce ECL, Thermo Fisher Scientific).
Protein Determination
Protein content was measured colorimetrically by the method of Bradford (59), using BSA (1 mg/mL) as standard.
Statistical Analysis
Data from behavioral and neurochemistry experiments were analyzed by unpaired t-test or 2-way ANOVA test, when appropriate, and are expressed as mean 6 SE. Statistical analyses were performed using the SPSS (Statistical Package for the Social Sciences) software on a PC-compatible computer. The values of t or F are presented only if p < 0.05.
RESULTS
Physical Development of the Animals
There were no significant differences in group body weights between saline and MMA-treated groups at 21 days 
Effect of MMA on Anxiety-like Behavior
Statistical analysis of the percentage of time and entries in the open arms in the elevated plus maze did not show a significant drug (saline and MMA) interaction in the 21-(t ¼ 1.73 and 0.016, respectively) and 40-day-old (t ¼ 0.43 and 1.59, respectively) animals. There was also no drug (saline or MMA) interaction for the percentage of time and entries in the enclosed arms in the 21-(t ¼ 0.60 and 1.36; p > 0.05, respectively) and 40-day-old (t ¼ 0.15 and 1.17; p > 0.05, respectively) animals, indicating that the treatment had no effect on anxiety-like behavior (Table) .
Effect of MMA on the RAM task
To investigate whether MMA treatment affected working and reference memory formation, the mice were 
Effect of MMA on Oxidative Stress
Because some studies have suggested that oxidative stress plays an important role in brain damage induced by MMA (60-62), we measured DCFH levels in the cerebral cortex, hippocampus and striatum of 21-and 40-day-old mice. Statistical analysis revealed that MMA injection induced an increase in DCFH levels in the cerebral cortex (t ¼ 4.3, p < 0.01; Fig. 5A ; t ¼ 4.41, p < 0.01, Fig. 5D ) and striatum (t ¼ 3.03, p < 0.01, Fig. 5C ; t ¼ 3.85, p < 0.01, Fig. 5F ) of 21-and 40-day-old mice, respectively. However, MMA injection increased DCFH levels only in the hippocampus of 40-day-old mice (t ¼ 3.0, p < 0.01, Fig. 5B ) mice but not in the hippocampus of 21-day-old mice (t ¼ 0.09, p > 0.05, Fig. 5E ).
Effect of MMA on Inflammatory Biomarkers
In addition to the involvement of oxidative stress, inflammation may play an important role in the brain damage induced by MMA (22, 23) . Therefore, we measured TNF levels in the cerebral cortex, hippocampus, and striatum of 21-and 40-day-old mice. MMA injection increased TNF levels vs controls in the 21-and 40-day-old mice in the cerebral cortex (t ¼ 13.71, p < 0.001, Fig. 6A ; t ¼ 8.376, p < 0.05, Fig. 6D) , hippocampus (t ¼ 20.79, p < 0.001, Fig. 6B ; t ¼ 7.405, p < 0.05, Fig. 6E ), and striatum (t ¼ 9.754, p < 0.001, Fig. 6C ; t ¼ 5.096, p < 0.05, Fig. 6F ), respectively.
MMA injection also induced an increase in IL-1b levels in the cerebral cortex (t ¼ 3.32, p < 0.05, Fig. 7A ; t ¼ 3.23, p < 0.05, Fig. 7D ), and striatum (t ¼ 3.54, p < 0.05, Fig. 7C ; t ¼ 4.35, p < 0.05, Fig. 7F ) in 21-and 40-day-old mice, respectively. However, in the 21-and 40-day-old mice, increased IL-1b levels were not observed in the hippocampus (t ¼ 1.35, p > 0.05, Fig. 7B ; t ¼ 1.52, p > 0.05, Fig. 7E ).
Because recent studies suggested the involvement of the cholinergic pathways in brain immune responses (63, 64) , we determined AChE activity in the cerebral cortex, striatum and hippocampus of the mice. MMA injection increased AChE activity in the cerebral cortex (t ¼ 5.9, p < 0.0001, Fig. 8A ; , D) , CWME (B, E), and ICWME (C, F). Data are expressed as the means 6 SE for n ¼ 10-15 in each group. Significance was determined as *p < 0.05 vs the control group. t ¼ 5.7; p < 0.0001, Fig. 8D ), striatum (t ¼ 39.7, p < 0.0001, Fig. 8C ; t ¼ 7.5, p < 0.0001, Fig. 8F ), and hippocampus (t ¼ 32.73, p < 0.0001, Fig. 8B ; t ¼ 14.3, p < 0.0001, Fig. 8E ), of 21-and 40-day-old mice, respectively.
Effect of MMA on Markers of Apoptosis
A previous study showed increased numbers of apoptotic cells in the brains of mouse pups after MMA injection (24) . Here, we found increases in the activation of caspases 1, 
Effect of MMA on Brain Histology
Histologic differences were not observed in the cerebral cortex, hippocampus, or striatum between control and MMAtreated 21- (Fig. 12A ) and 40-day-old (Fig. 12B) , animals. 
Effect of MMA on CD11b, GFAP, and Neurons
Microglial (CD11b) and astrocyte (GFAP) immunoreactivity was increased in the cerebral cortex 21 and 40 days after MMA administration. In controls and at 21 days after MMA injection, small numbers of GFAP-labeled astrocytes were observed (Fig. 13A-C) , whereas at 40 days after injection there was increased GFAP in the cerebral cortex (Fig. 13D) . In controls there was minimal immunostaining for CD11b (Fig.   13E , G), whereas at both 21 and 40 days after MMA injection there was an increase in CD11b immunoreactivity in the cerebral cortex (Fig. 13F, H) .
Representative photomicrographs from day 21 of the hippocampal CA1 (Fig. 14A, D , G, J), CA3 (Fig. 14B, E , H, K), and dentate gyrus (DG) (Fig. 14C, F, I , L) from saline-and MMA-treated mice and from day 40 of CA1 (Fig. 15A, D, G, J) , CA3 (Fig. 15B, E, H, K) , and DG (Fig. 15C, F, I , L) from saline-and MMA-treated mice demonstrate increased microglial (CD11b) and astrocyte (GFAP) immunoreactivity vs that in controls.
Similarly, in the striatum, there was increased GFAP immunoreactivity over controls at 21 and 40 days after MMA administration (Fig. 16A-D) ; CD11b immunoreactivity was only increased over controls at 40 days after MMA injection (Fig. 16E-H) .
Western blot of homogenates from the cerebral cortex at 21 days after MMA administration demonstrates an increase in GFAP in the cerebral cortex vs the control group (3-4 per group) (Fig. 17) .
Cresyl violet staining of the hippocampus, cerebral cortex and striatum at 21 and 40 days after MMA administration showed no detectable effects of MMA on neuronal morphology or numbers vs controls (Fig. 18) .
DISCUSSION
We provide evidence for the first time that neuroinflammation and glial dysfunction induced by an acute and transient metabolic insult with MMA is sufficient to initiate pathological processes that lead to cerebral dysfunction and cognitive impairment. We found that acute MMA administration at doses that raised its concentration in the brain comparable to that in affected patients (36, 37) caused memory deficits and increased levels of TNF, DCFH, caspases, and AChE activity in the cerebral cortex, hippocampus and striatum of 21-and 40-day-old mice. Interestingly, IL-1b levels also increased in the striatum and cerebral cortex in both groups of treated mice. In addition, we identified increased microglial (CD11b) and astrocyte (GFAP) immunoreactivity in the striatum, hippocampus and cerebral cortex after MMA administration in mice; this was not associated with apparent neuronal death, as assessed with H&E and Cresyl violet stains.
Acute MMA administration had no effect on the body weight, implying that acute injection did not cause malnutrition in the animals (Figs. 1, 2) . Similarly, the same treatment did not change the performance of mice in the open field (Fig. 3) , or elevated plus maze tasks, indicating that this organic acid was not apparently anxiogenic in 21-and 40-dayold mice (Table) .
MMA exposure during the neonatal period was sufficient to trigger a deficit in working memory (WM), suggesting that cognitive deficits can be related to the effect of acute MMA administration, mainly in the basal ganglia. In agreement with this view, it has been demonstrated that the WM is expressed as a disturbance of executive functions (65, 66) . This alteration is often related to lesions in the striatum and is interpreted as an inability to inhibit ongoing action or as a failure to initiate a response (65) . On the other hand, the protocol of MMA injection used had no effect on reference memory. Because reciprocal connections of the striatum, prefrontal cortex, and parietal cortex with the hippocampus are important to WM (67, 68) , it is plausible to propose that hippocampal alterations were not sufficient to cause a spatial cognitive deficit but contributed to the WM impairment observed in this model of methylmalonic acidemia (69) . Our results coincide with clinical studies showing that patients with methylmalonic acidemia develop cognitive impairment and striatal dysfunction concurrent with neuroimaging abnormalities in the striatum and other brain regions, mainly after catabolic or infectious events (70, 71) .
Inflammation and oxidative damage are also found in the brains of patients with methylmalonic acidemia (20, 21, 23, 63, 71) . In this context, studies suggest that TNF and IL-1b play a role in the pathogenesis of methylmalonic acidemia (22, 23) . It is important to note that neutrophils are usually not present in the CNS because they do not ordinarily cross the blood-brain barrier; thus, microglia are the primary immune effectors (72) . Microglia are one of the cell types responsible for the production of pro-inflammatory cytokines such as IL-1b and TNF, which also act as modulators of neurotransmission within the brain (73) . In line with this view, we showed here that MMA induced enhanced microglial and astrocyte activation as assessed both by immunohistochemistry and Western blot for GFAP. These alterations coincided with increased TNF in all of the structures Methylmalonate Neurotoxicity in Neonatal Mice studied, thus supporting a link these events with WM deficit. Acute MMA administration also increased IL-1b levels in the cerebral cortex and striatum. Because the MMA was administered directly into the CNS, we suggest that the observed increase of IL-1b and TNF may be a consequence of the glial activation induced by the MMA; this could cause dysfunction in the developing brain, triggering behavioral alterations (74) . Current evidence indicates that cytokines, particularly TNF, increase neuronal excitability by activating TNF receptors (75) . Cerebral TNF receptors stimulation directly induces excitotoxicity through the activation of N-methyl-D-aspartate (NMDA) receptors (76) , and indirectly by inhibiting glial glutamate transporters on astrocytes (77) . In addition, IL-1b stimulates its cerebral receptor and can induce Src kinase-mediated tyrosine phosphorylation of the NR2B subunit of the NMDA receptor (78) . As a consequence, TNF and IL-1b facilitate NMDA receptor-mediated Ca 2þ influx into neurons, promoting excitotoxicity (78) . Considering that these cytokines can inhibit glutamate uptake in astrocytes (79) and increase its glial release (80), it is plausible to propose that the increases of these proinflammatory cytokines result in elevated extracellular glutamate levels and toxicity in this model. In line with this view, a considerable body of evidence has demonstrated that excessive glutamate receptor stimulation, in particular the NMDA receptor, is a major pathway that leads to MMAinduced toxicity (81, 82) .
The excitotoxicity induced by IL-1b and TNF can also promote elevated concentrations of intracellular calcium, as well as the production of NO and increased H 2 O 2 (83) . These free radicals induce nitrosative/oxidative stress that may result in increased lipid peroxidation and DNA damage (84, 85) . Indeed, our data reveal that a single transient exposure to MMA induced an increase in DCFH (indicative of oxidative stress) in the cerebral cortex, hippocampus and striatum of mouse pups at 21 days and that remained until 40 days of life.
AChE has an important role in immune responses by rapidly hydrolyzing ACh (86) , which is known to have anti-inflammatory characteristics and to suppress the production of proinflammatory cytokines (87) . Other authors have demonstrated that the activation of nicotinic receptors in macrophages significantly reduced the liberation of proinflammatory cytokines, such as TNF and IL-1b, whereas the production of anti-inflammatory cytokines such as IL-10 was not affected (88) . In this way, AChE inhibitors reduce lymphocyte proliferation and the secretion of proinflammatory cytokines and may attenuate inflammation by increasing the ACh concentration in extracellular spaces (89) . Here, we observed an increase in the AChE activity in the striatum, hippocampus and cerebral cortex in MMA-exposed mouse pups. It is possible that this alteration leads to decreased ACh levels, contributing to the proinflammatory status. Although the role of the cholinergic system in methylmalonic acidemia is still unclear, the alterations in AChE activity support the view that this system may contribute to the regulation of immune responses in this acidemia, consequently leading to neurological manifestations. Indeed, loss of cholinergic neurons is associated with the occurrence of seizures and mental retardation in patients with metabolic inherited disorders (90) .
In addition to increases inflammatory biomarker levels, MMA also induced the activation of caspases 1, 3, and 8 in the striatum, hippocampus, and cerebral cortex from 21-and 40-day-old mice. The activation of caspase-1 may occur by its substrates such as TNF and IL-1b and reflect an increase of the cellular inflammatory response (91) . After TNF binding, its receptors can be internalized; this leads to the activation of executioner caspases such as caspase-8 through the extrinsic apoptosis pathway (92, 93) . In addition to its ability to induce apoptosis through the extrinsic pathway, caspase-8 also triggers the intrinsic apoptosis pathway by cleaving the proapoptotic Bcl-2 family members to initiate mitochondriainduced apoptosis (94, 95) . These events induce a subsequent increase in reactive species and a release of mitochondrial apoptogenic factors such as cytochrome c to the cytosol, consequently leading to the activation of caspase-3 and cellular damage (96) . In agreement with this view, there is also evidence of the activation of caspases-1, -3, and -8 in the brain of patients and in experimental models of Huntington disease induced by malonate (97) (98) (99) .
It is worth pointing out, however, that an elegant study showed that MMA did not increase caspase-3 in 3D rat organotypic brain cultures (24) . The most striking differences between our study and the study of Jafari et al are methodological, i.e. the use of mice and in vivo treatment in our study vs the use rats and in vitro treatment in their study. However, this is only a supposition and would require more experiments to verify the possibility of neuroinflammatory or apoptotic processes in other brain structures and methylmalonic acidemia models.
Indeed, in another model of methylmalonic acidemia, it was observed that the acetate [U-14C] incorporation into lipids of the cerebral cortex was reduced by MMA, which may explain the hypomyelination and/or demyelination observed in some methylmalonic acidemia patients. In the context of the present study, we hypothesize that this is mediated by the immune system (100, 101). Moreover, experimentally or clinically, cytokines interfere directly or indirectly in the process of memory consolidation, synaptic plasticity and/or neurogenesis, and expression of neuroinflammatory and apoptosis mediators, potentially implying that neuronal dysfunction leads to cognitive impairments (102) .
Our results suggest that glial cells but not neurons can be the first cells targeted in methylmalonic acidemia. The fact that animals lacking MCM activity and exhibiting increased MMA levels show extensive white matter alterations but not apparent neuronal loss (100, 101) suggests specific vulnerability of glial cells to MMA during development or repair processes. In fact, McLaughlin et al did not observe neuronal death after MMA exposure (5 or 50 mM) in striatal and cortical cultures from embryonic rat brains (103) . Furthermore, Writer and Schillerstrom reported that cognitive deficits in patients after traumatic brain injury are not always correlated with loss of the neuronal cells (104) . Thus, we propose that sustained astrocyte proliferation could participate in the early neurological manifestations that precede neurodegeneration and that have been described in a number of methylmalonic acidemia patients, such as those with cerebral atrophy (69, 70) . However, further in-depth studies are necessary to clarify the relationship between MMA exposure and neuronal death.
Taken together, all experimental findings suggest that oxidative stress MMA-induced impairs the intrinsic cell potential, leading to inflammatory signals and proliferation glial causing activation of caspases by extrinsic and intrinsic apoptosis pathways. It is tempting to propose that the effects observed in the present study may contribute, at least in part, to the neurological dysfunction found in patients with methylmalonic academia, and they suggest the importance of early neonatal screening for MCM (L-methylmalonyl-CoA mutase) deficiency. Furthermore, although many questions remain regarding the pathogenesis and treatment of methylmalonic acidemia, the administration of compounds with potential anti-inflammatory and antiapoptosis effects might represent a complementary therapy in the treatment of children with this disorder.
